Tirzepatide
Tier 1: $360 (2.5-5mg) | Tier 2: $500 (7.5-10mg) | Tier 3: $700 (12.5-15mg)
Tirzepatide mimics two hormones instead of one (GLP-1 and GIP), producing stronger appetite suppression and greater weight loss than semaglutide. Clinical trials show 20-25% average body weight loss. Many users report fewer waves of nausea compared to semaglutide.
Interested in Tirzepatide?
Our medical team will evaluate if this medication is right for you during your consultation.
Dosage & Administration
Weekly subcutaneous injection on the same day each week for 12-16+ weeks. Dose range: 2.5-15mg weekly with 4-week titration intervals. Keep refrigerated for up to 28 days.
Important: Like any prescribed medication, dosing varies from person to person. Always follow the dosage prescribed by your healthcare provider. Optimize 360 personalizes every protocol based on your labs, symptoms, and goals.
Side Effects
- Nausea: Common but often milder than semaglutide.
- Diarrhea/Constipation: GI changes during titration.
- Injection Site Reactions: Mild redness or swelling.
- Decreased Appetite: Expected therapeutic effect, not a side effect per se.
While often better tolerated than semaglutide, tirzepatide is still a serious medication with real side effects. Medical supervision is essential.
Why Choose Optimize 360 for Tirzepatide
- Prescribed and monitored by Dr. Steve Farmer — 30+ years in hormone medicine
- Comprehensive lab work before prescribing — we never guess
- Sourced from licensed U.S. compounding pharmacies
- Transparent pricing — the price above is what you pay, no hidden fees
- Telehealth available nationwide — medications shipped to your door
- Unlimited messaging with your provider throughout treatment
Get Started Today
No memberships. No referral needed. Schedule your consultation and we'll take it from there.
Related
How Tirzepatide Works
Tirzepatide is a dual-agonist peptide that simultaneously activates two incretin hormone receptors: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). GLP-1 activation reduces appetite, slows gastric emptying, and enhances insulin secretion. GIP activation complements these effects by improving insulin sensitivity, enhancing fat metabolism, and potentially increasing energy expenditure. This dual mechanism produces more potent metabolic effects than GLP-1-only medications like semaglutide. Tirzepatide is the active ingredient in Mounjaro (for diabetes) and Zepbound (for weight management).
Benefits & Clinical Evidence
The SURMOUNT clinical trial program demonstrated that tirzepatide produces industry-leading weight loss — participants on the highest dose lost an average of 22.5% of body weight over 72 weeks. The SURPASS trials for type 2 diabetes showed superior A1C reduction compared to semaglutide, insulin, and placebo. Beyond weight and glucose, tirzepatide has shown improvements in blood pressure, triglycerides, waist circumference, and inflammatory markers. Some studies suggest potential cardiovascular benefits, with dedicated cardiovascular outcome trials ongoing. Tirzepatide represents the most effective non-surgical weight management tool currently available.
Who Is a Good Candidate?
Tirzepatide is appropriate for patients with obesity (BMI 30+) or overweight (BMI 27+) with at least one weight-related comorbidity (hypertension, dyslipidemia, type 2 diabetes, sleep apnea). It may also benefit patients who have plateaued on semaglutide or who need more potent metabolic intervention. Patients should be committed to concurrent lifestyle modifications — nutrition and physical activity — as tirzepatide is most effective when combined with behavioral changes. A thorough medical evaluation including metabolic labs, thyroid function, and personal/family history is required before initiation.
What to Expect: Treatment Timeline
Appetite reduction is typically noticed within the first week. Many participants lost 3-5% of body weight in the first month in clinical trials. Individual results may vary.. Significant weight loss (10-15%) develops over 3-6 months. Maximum effects are seen at 9-12+ months. Tirzepatide is injected subcutaneously once weekly, starting at the lowest dose (2.5 mg) and titrating upward every 4 weeks as tolerated. Slow titration minimizes gastrointestinal side effects. Lab work is monitored regularly to track metabolic improvements. Available at Optimize 360 from $360/month starting.
Side Effects & Safety
The most common side effects are gastrointestinal: nausea, diarrhea, vomiting, constipation, and decreased appetite. These are most prominent during dose escalation and typically improve over time. Slow titration is the primary management strategy. Less common effects include injection site reactions, fatigue, and hair thinning (related to rapid weight loss rather than the drug itself). Tirzepatide is contraindicated in patients with personal or family history of medullary thyroid carcinoma or MEN2 syndrome. Pancreatitis risk, while low, requires monitoring.
Frequently Asked Questions
A: Head-to-head data and cross-trial comparisons suggest tirzepatide produces greater weight loss than semaglutide — approximately 22.5% vs 15-17% body weight reduction in clinical trials. Tirzepatide's dual GLP-1/GIP mechanism is believed to account for this difference. Both are effective, but tirzepatide may be preferred for patients needing more aggressive weight management or who have plateaued on semaglutide.
A: Studies show that weight regain is common after discontinuation, as the biological drivers of weight (appetite regulation, metabolic rate) return to baseline. Long-term or maintenance dosing strategies, combined with sustained lifestyle changes, help mitigate this. Your provider will work with you on a long-term plan that may include dose reduction rather than abrupt discontinuation.
A: Yes. Many Optimize 360 patients use tirzepatide alongside testosterone replacement or female hormone therapy. Weight loss from tirzepatide can actually improve hormonal profiles — reducing aromatization in men and improving metabolic markers in both sexes. Your provider will coordinate your full protocol.
Also Available